Recent Finacing
Recent Raise
Poplar Therapeutics is a clinical-stage immunology company developing PHB-050, a next-generation anti-IgE antibody for treating food allergy and other atopic diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
